Stockreport

COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation
PDF Dermal filler program with AbbVie in clinical phaseRegenerative breast implant program large-animal study underway to evaluate commercial-size implants with topline data [Read more]